SMA 200 spoločnosti Abeona Therapeutics Inc
Aká je hodnota metriky SMA 200 spoločnosti Abeona Therapeutics Inc?
Hodnota metriky SMA 200 spoločnosti Abeona Therapeutics Inc je $6 +0.08%
Aká je definícia metriky SMA 200?
SMA 200 (Simple Moving Average 200) je priemerná cena akcie za posledných 200 dní vypočítaná ako nevážený priemer z predchádzajúcich 200 záverečných cien.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Abeona Therapeutics Inc
Čomu sa venuje spoločnosť Abeona Therapeutics Inc?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Firmy s metrikou sma 200 podobnou spoločnosti Abeona Therapeutics Inc
- Hodnota metriky SMA 200 spoločnosti Applied Dna Sciences Inc je $6 -269.28%
- Hodnota metriky SMA 200 spoločnosti Voya International High Dividend Equity Income Fund je $6 +0.00%
- Hodnota metriky SMA 200 spoločnosti MDC Partners je $6 -2.95%
- Hodnota metriky SMA 200 spoločnosti Riskified je $6 -21.88%
- Hodnota metriky SMA 200 spoločnosti Ferratum Oyj je €6 -12.67%
- Hodnota metriky SMA 200 spoločnosti Zevra Therapeutics Inc je $6 +3.90%
- Hodnota metriky SMA 200 spoločnosti Abeona Therapeutics Inc je $6 +0.08%
- Hodnota metriky SMA 200 spoločnosti Biodelivery Sciences International je $6 +0.00%
- Hodnota metriky SMA 200 spoločnosti Antares Pharma Inc je $6 +0.00%
- Hodnota metriky SMA 200 spoločnosti Chesswood je CAD$6 -521.14%
- Hodnota metriky SMA 200 spoločnosti Lantern Pharma je $6 -50.31%
- Hodnota metriky SMA 200 spoločnosti Nuveen Credit Strategies Income Fund je $6 +5.37%
- Hodnota metriky SMA 200 spoločnosti IMP Powers je ₨6 +0.00%